Ketamine Infusion for Comorbid PTSD and Chronic Pain
Status:
Completed
Trial end date:
2019-06-04
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the effectiveness of low dose IV ketamine infusion
in the treatment of patients with PTSD and comorbid chronic pain.
Hypothesis: A single ketamine infusion should be associated with significantly greater
reduction in core PTSD symptom levels after the treatment and such an effect is not only due
to its analgesic properties but also through unknown mechanism of action that maybe related
to NMDA/AMPA receptor modulation.